BriefTea
Every story in sixty words
Get the free app no ads · no paywallHealth · 5 August 2026
Researchers are inviting people in Bradford to trial a new GLP-1 weight loss drug, which is given as a weekly injection. Steven Lindsay, the chief investigator, stated that it might prove more efficacious and produce fewer adverse reactions. Bradford Teaching Hospitals NHS Trust seeks participants aged 18 or above who are either obese or overweight.
Reported by BBC · How we write briefs
Understand this story
What are GLP-1 drugs? What is 'obese or overweight'? Who pays for drug trials?More briefs
WorldUS brain fungus cases quadruple in two years Health82% of therapists say normal emotions are now 'illnesses' HealthScience Corp implants PRIMA vision chip in first Stargardt patient, who reads a word HealthTwo HRT patch brands, Estradot and FemSeven Conti, are in short supply WorldIndonesia Tests Dry Ice to Clear Toxic Wildfire Haze PoliticsMore Seven-Year-Olds Than 50-Year-Olds Get Disability Benefits More health stories → Browse all stories →We would like to count visits and see which links bring readers here. That means storing a random ID in your browser. No cookies, no ads, no profile. How it works.